Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-Interventional Study (NIS) in Patients With Restless Legs Syndrome (RLS) to Assess the Effectiveness and Safety of Neupro® in Daily Practise

NCT01113710 is registered in ClinicalTrials.gov with UCB Pharma as lead sponsor.

NCT NCT01113710
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01113710 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-Interventional Study (NIS) in Patients With Restless Legs Syndrome (RLS) to Assess the Effectiveness and Safety of Neupro® in Daily Practise
Lead sponsor
UCB Pharma
Phase
Observational
Overall status
Completed
Start date
May 31, 2010
Completion date
July 31, 2011
Enrollment
687 (actual)
Sites
80

Conditions

As the registry lists them; a condition with its own page is linked.

idiopathic restless legs syndrome